Actively Recruiting

Age: 18Years +
All Genders
ID07122427

Aging of the Vascular Wall

Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2025-08-20

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Demographic aging is a major social change of the 21st century, affecting the function of cells, tissues, and organs. This decline raises the risk of diseases like cancer, neurodegenerative disorders, and cardiovascular diseases (CVD), the leading cause of death worldwide. Aging causes changes in blood vessels and platelet function, increasing cardiovascular risks. This research explores how different blood vessels, such as arteries and veins, age at the molecular and physiological levels, which is not well understood yet. The study observes patients aged 18 and older who need coronary artery bypass grafting (CABG). Participants are grouped by age: young adults (18-30), middle-aged adults (30-60), and elderly adults (60+). During surgery, samples of venous and arterial grafts, including the internal mammary artery and great saphenous vein, are collected for analysis. This procedure helps study the aging markers in different types of blood vessels. Participants contribute by undergoing CABG surgery where graft samples are collected on the day of surgery. Researchers measure biomarkers of aging from these samples to compare aging in various vessel types. The study focuses on understanding vascular aging without extra interventions. The total participation involves the surgical procedure and related sample collection, with ongoing monitoring as needed. The study is led by the Centre Hospitalier Universitaire de Saint Etienne and will conclude in December 2026.

CONDITIONS

Brief Title

Aging of the Vascular Wall

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Major patients requiring coronary artery bypass grafting (CABG).
Not Eligible

You will not qualify if you...

  • Hypertension
  • Diabetes
  • Systemic inflammatory disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - Day 1

Participants undergo coronary artery bypass grafting (CABG) during which vascular graft samples are collected.

1 surgical procedure visit

Long-term Monitoring

Duration - Up to study completion in December 2026

Participants are observed for biomarkers of aging following surgery.

Trial Site Locations

Total: 1 location

1

CHU Saint-Etienne

Saint-Etienne, France, France, 42055

Actively Recruiting

Loading map...

Research Team

A

Anne-Claire DUCHEZ, PhD

S

Salvatore CAMPISI, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

Mechanisms Underlying Carbon Dioxide Induced Protein Efflux ...

Traumatic Brain Injury

Actively Recruiting

1 location

DC Longitudinal Study on Aging and Specimen Bank

Alzheimer Disease

Actively Recruiting

1 location

Evaluation of the Efficiency of the PRPP Task Analysis Syste...

Mental Health

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here